I think 51 is the line to watch and not 52.
AggiePeeps06 said:
Aren't tax cuts already baked into the stock price so expectations on earnings are already high?
pfo said:AggiePeeps06 said:
Aren't tax cuts already baked into the stock price so expectations on earnings are already high?
Yes but are they high enough? For instance, Merrill Lynch is projecting 20% earnings growth for the S&P 500 for 2018. What multiple should 20% earnings growth sell at....20,21? Currently the S&P is selling for about 17-17.5 X. If the multiple would go to 20, then the S&P would sell at 3,000 or about 14% higher by the end of the year.
leoj said:
It was Israel, we're good
Corrected the math.IrishTxAggie said:
Enjoy your ~25%!
They're wrapping up a Phase 3 and already approved in the EU for a first-line advanced renal cell carcinoma. This Phase 3 trial was at the request of the FDA for a larger trial to see if the results are duplicated because of a hard ass on the panel. They came out on early January (I think) saying the trial is continuing as designed with no changes to protocol.oldarmy1 said:Appreciate it! I bought 50k shares and sold 35k at $2.45. Not a bad 2 day trade and now my net holding price on 15k shares is $1.49. I can hold with confidence from here.IrishTxAggie said:
Enjoy your ~25%!
Thanks again!
And if I knew more about the company I'd likely have held it all based on that Friday huge volume day. That chart is exactly what I have mentioned to look for and asked people to post when they see them happening.
I know the feeling. I'm sitting on a very sizable chunk and the urge to dump everything into it is strong. I've already broken one of my rules with acquiring so much of this stock.what say you said:
reading this makes me want to put my life savings into it. i won't of course, but it sounds really positive.
When I realized I'm still a lolpoor...oldarmy1 said:
I bought 50k shares
We will get there. Invest wisely.aggielax48 said:When I realized I'm still a lolpoor...oldarmy1 said:
I bought 50k shares
I still have them. $1100 sitting at $600. Holding to see if anything tomorrow but not liking the S&P rejection move through the afternoon. Resistance hit and slipped all afternoon.AggiePeeps06 said:
You still holding the GE $13.50 calls? Not getting the move we were looking for quick enough to offset the decay
Well if there is a conference tomorrow and you really think something big coming grab some April 20 $3 options. One thing we know is there were over 9 million shares traded Friday and today less than a million, so the larger buyers certainly did not take profits.IrishTxAggie said:
Not sure. There was no scheduled call for tomorrow that I'm aware of, but I believe they are supposed to present at a conference in Europe this week. Towards the end of last year, It was floated that Jazz Pharmaceuticals was interested in acquiring and the price floated was in the $14-18/share. Jazz has the licensing agreement in the EU for FOTIVDA. They could be trying to get a buyout agreement in place before the new Phase 3 readout catalyst because if the readout is as everyone suspects it should be, AVEO could see $7+ very quickly and a buyout would be imminent from there.